Trial intelligence / Profile preview

Astragalus for Cardiac and Kidney Protection in Metabolic Syndrome

NCT01847807Phase 3Completed

Sponsor
Lanzhou University
Start
Jan 2011
Primary completion
Jun 2015
Modality
Herbal supplement
Countries
1
01

Overview

A Phase 3 trial of astrgalus in metabolic syndrome, sponsored by Lanzhou University. Started Jan 2011; status: completed.

02

Drugs

astrgalus
03

Conditions

metabolic syndrome

Beyond the preview

Go deeper on NCT01847807.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01847807.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call